AI, S. F., A, B. R., E, B. D., LA, V. S., R, V. S. C., A, F. E., . . . I, P. F. (2023). Sodium-glucose cotransporter-2 inhibitor therapy in kidney transplant patients with type 2 or post-transplant diabetes: An observational multicentre study.
Citación estilo ChicagoAI, Sánchez Fructuoso, et al. Sodium-glucose Cotransporter-2 Inhibitor Therapy in Kidney Transplant Patients With Type 2 or Post-transplant Diabetes: An Observational Multicentre Study. 2023.
Cita MLAAI, Sánchez Fructuoso, et al. Sodium-glucose Cotransporter-2 Inhibitor Therapy in Kidney Transplant Patients With Type 2 or Post-transplant Diabetes: An Observational Multicentre Study. 2023.
Precaución: Estas citas no son 100% exactas.